| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥36.6B | ¥38.0B | -3.8% |
| Operating Income | ¥0.3B | ¥0.6B | -58.8% |
| Ordinary Income | ¥0.3B | ¥0.7B | -59.6% |
| Net Income | ¥0.3B | ¥0.4B | -19.5% |
| ROE | 2.6% | 3.4% | - |
FY2026 Q3 cumulative results (April-December 2025): Revenue 36.6B yen (YoY -3.8%), Operating Income 0.3B yen (YoY -58.8%), Ordinary Income 0.3B yen (YoY -59.6%), Net Income 0.3B yen (YoY -19.5%). The company operates in the health natural foods wholesale business as a single segment. Revenue declined while profitability deteriorated sharply, with operating margin compressing to 0.7% from 1.5% in the prior year period. Despite a maintained gross profit margin of 25.2%, high selling, general and administrative expenses at 9.0B yen consumed most of the gross profit, resulting in minimal operating profitability. The results reflect a revenue down/profit down pattern, with structural challenges in cost control becoming more pronounced.
Revenue declined 1.4B yen to 36.6B yen, representing a -3.8% YoY contraction. As a single-segment operator in health natural foods wholesale, the top-line decline reflects market demand softness and competitive pressures in the distribution channel. Gross profit reached 9.2B yen with a margin of 25.2%, showing resilience in pricing and product mix despite lower volumes. The primary profit pressure emerged at the operating level, where SG&A expenses of 9.0B yen represented 24.5% of revenue, leaving only 0.3B yen in operating income. This represents a sharp 58.8% YoY decline from 0.6B yen, indicating that fixed cost absorption deteriorated as revenue fell. The operating margin compressed 0.9 percentage points from 1.5% to 0.7%, highlighting structural inefficiency in the cost base.
Non-operating items contributed minimally, with non-operating income of 0.1B yen including dividend income of 0.04B yen, offset by non-operating expenses of 0.1B yen primarily from interest expense of 0.06B yen. Ordinary income of 0.3B yen declined 59.6% YoY, tracking the operating performance decline closely.
Extraordinary items had material impact on net income composition. Extraordinary gains of 0.2B yen included asset sale gains of 0.1B yen and investment securities sale gains of 0.1B yen, while extraordinary losses of 0.1B yen resulted from asset disposals. These non-recurring items totaled approximately 21.8% of net income, indicating elevated reliance on one-time gains to support bottom-line results. Income tax expense was minimal at 0.04B yen, resulting in net income of 0.3B yen, down 19.5% YoY but supported by the extraordinary gains.
This represents a revenue down/profit down pattern, driven by top-line weakness and operating leverage deterioration. The reliance on non-recurring items to cushion net income decline raises concerns about underlying earnings quality and sustainability.
[Profitability] ROE stands at 2.6%, significantly below prior levels, driven by net profit margin compression to 0.9% and operating margin of 0.7%. The operating margin of 0.7% represents substantial deterioration from 1.5% in the prior year, reflecting poor cost absorption as revenue declined. Basic EPS decreased to 45.11 yen from 56.02 yen YoY. [Cash Quality] Cash and deposits reached 14.5B yen, providing coverage of 2.24x against short-term borrowings of 6.5B yen. Trade receivables increased to 9.6B yen, up 40.1% YoY, resulting in days sales outstanding of approximately 95 days, indicating collection延長. [Investment Efficiency] Asset turnover measured 1.05x, maintaining reasonable asset utilization. [Financial Health] Equity ratio stands at 34.3% with total equity of 11.9B yen against total assets of 34.8B yen. Current ratio of 178.5% and quick ratio of 157.6% indicate adequate liquidity coverage. Debt-to-equity ratio is 0.84x, with interest-bearing debt of 10.0B yen. Short-term debt represents 64.7% of total liabilities, creating refinancing concentration risk. Retained earnings increased modestly to 1.8B yen.
Cash and deposits increased 2.0B yen YoY to 14.5B yen, reflecting accumulated liquidity despite profitability pressures. Operating profit generation of 0.3B yen contributed to cash accumulation, though operating efficiency deteriorated significantly. Trade receivables expanded 2.7B yen to 9.6B yen, representing a 40.1% increase that suggests extended collection cycles and working capital consumption. This receivables buildup occurred concurrent with a 3.8% revenue decline, indicating collection延長 that may pressure operating cash generation. Trade payables increased 3.1B yen or 91.7% to 7.9B yen, reflecting extended payment terms with suppliers and working capital management tactics to preserve short-term liquidity. Short-term borrowings rose 1.6B yen or 32.2% to 6.5B yen, indicating increased reliance on bank credit to fund working capital needs. The combination of receivables growth, payables extension, and borrowing increase suggests active working capital management to maintain liquidity amid operating headwinds. Cash coverage of short-term liabilities stands at 2.24x for borrowings and 0.91x for total current liabilities, indicating adequate but declining liquidity cushion. Investment securities holdings of 1.5B yen provide potential liquidity sources. The net defined benefit liability of 1.3B yen represents a long-term obligation. The 0.2B yen unrealized gain on securities in comprehensive income suggests modest portfolio appreciation.
Ordinary income of 0.3B yen versus operating income of 0.3B yen shows minimal net non-operating impact, with non-operating income of 0.1B yen offset by non-operating expenses of 0.1B yen. Non-operating income comprised primarily dividend income of 0.04B yen and other non-operating income, representing approximately 0.3% of revenue and reflecting limited contribution from financial activities. Interest expense of 0.06B yen relative to operating income indicates an interest coverage ratio of 4.7x, manageable but sensitive given the thin operating margin. The material earnings quality concern emerges from extraordinary items, which totaled 0.2B yen in gains and 0.1B yen in losses, with net extraordinary income of approximately 0.1B yen. Investment securities sale gains of 0.1B yen and asset sale gains of 0.1B yen are non-recurring by nature. These extraordinary items represent approximately 21.8% of net income, indicating that more than one-fifth of reported earnings stem from non-recurring sources rather than core operations. Comprehensive income of 0.5B yen exceeded net income of 0.3B yen, with the 0.2B yen difference attributable to valuation gains on investment securities. The significant proportion of non-recurring items relative to core operating profit raises concerns about earnings sustainability and the quality of reported results.
Full-year guidance projects revenue of 51.2B yen (YoY +3.4%), operating income of 0.3B yen (YoY -54.5%), ordinary income of 0.3B yen (YoY -54.0%), and net income of 0.2B yen. Q3 cumulative progress rates stand at 71.5% for revenue, 86.7% for operating income, and 93.3% for ordinary income. Revenue progress of 71.5% against the 75% standard for Q3 indicates slightly behind-pace performance, suggesting Q4 requires 14.6B yen or approximately 40% quarterly growth to meet guidance. Operating income progress of 86.7% is ahead of the standard rate, but the absolute level of 0.3B yen for the full year implies minimal profitability. The guidance assumes Q4 operating income of approximately 0.04B yen, indicating continued margin pressure. The company has not revised guidance during this quarter, suggesting management maintains its outlook despite underlying operational challenges. No forecast assumptions or order backlog data are disclosed to assess forward visibility. The projected full-year operating margin of 0.6% represents structural profitability challenges requiring cost structure reform to achieve sustainable improvement.
Annual dividend is forecast at 20.00 yen per share for the full fiscal year, unchanged from prior guidance. Based on the forecast EPS of 22.87 yen, the payout ratio calculates to 87.5%, representing a high distribution rate relative to earnings. Against actual Q3 cumulative EPS of 45.11 yen, the 20.00 yen dividend represents a payout ratio of 44.3%, which appears more sustainable. The elevated forecast payout ratio reflects weaker anticipated Q4 earnings. Dividend policy appears committed to maintaining the 20.00 yen level despite profitability pressures. No share buyback programs are disclosed. With cash reserves of 14.5B yen against approximately 0.14B yen in annual dividend payments (20 yen x 700K shares), the company maintains adequate cash coverage of 103x for dividend obligations. However, the sustainability of dividends depends critically on operating cash flow generation, which faces pressure from working capital consumption evident in receivables buildup. The total return ratio equals the payout ratio at 87.5% for forecast figures, as no buybacks are indicated.
Market demand volatility for health natural foods represents the primary business risk, with the single-segment concentration leaving no diversification buffer. The 3.8% YoY revenue decline in Q3 cumulative demonstrates vulnerability to sector-specific headwinds and intensifying competition in distribution channels. Trade receivables collection延長 poses significant cash conversion risk, with receivables increasing 40.1% YoY to 9.6B yen while revenue declined 3.8%, resulting in DSO extending to approximately 95 days. This deterioration in collection efficiency threatens operating cash flow generation and may necessitate increased borrowing to fund working capital. Short-term debt refinancing concentration creates liquidity risk, with short-term borrowings increasing 32.2% to 6.5B yen and representing 64.7% of total liabilities. This maturity profile requires successful rollover of facilities and exposes the company to potential credit tightening or rate increases. The combination of thin operating margins (0.7%), elevated working capital needs, and short-term debt concentration creates vulnerability to operational or market disruptions.
[Industry Position] (Reference - Proprietary Analysis)
The company's profitability metrics fall substantially below industry medians. ROE of 2.6% compares unfavorably to the trading industry median of 6.4% (IQR: 2.4%-9.9%, n=19), positioning in the bottom quartile. Operating margin of 0.7% significantly underperforms the industry median of 3.2% (IQR: 1.7%-4.9%, n=17), indicating structural cost inefficiency relative to peers. Net profit margin of 0.9% trails the industry median of 2.7% (IQR: 1.3%-6.0%, n=19), reflecting the company's challenged profitability profile.
Financial health metrics show mixed positioning. Equity ratio of 34.3% falls below the industry median of 46.4% (IQR: 39.6%-52.6%, n=19), indicating higher leverage relative to peers. Current ratio of 178.5% (1.79x) is below the industry median of 1.88x (IQR: 1.64x-2.38x, n=15), though remaining within acceptable liquidity ranges.
Working capital efficiency presents concerns. Receivables turnover at approximately 95 days compares unfavorably to the industry median of 79 days (IQR: 67-103 days, n=18), indicating slower collection than typical peers. Payables turnover calculation suggests approximately 105 days versus industry median of 78 days (IQR: 63-98 days, n=17), reflecting extended supplier payment terms.
Growth metrics lag industry performance. Revenue decline of -3.8% YoY contrasts with industry median growth of +5.0% (IQR: -5.0% to +7.8%, n=19), positioning the company in the bottom half of the distribution. The combination of negative revenue growth and margin compression results in EPS decline versus industry median EPS growth of +0.24 (IQR: 0.00-1.07, n=19).
Return on invested capital of 3.3% falls below industry median ROIC of 4.0% (IQR: 2.0%-13.0%, n=17), indicating suboptimal capital efficiency. Asset turnover of 1.05x aligns closely with industry median of 1.00x (IQR: 0.62-1.20, n=19), suggesting asset utilization is competitive despite operational challenges.
※ Industry: Trading (19 companies), Comparison: FY2025 Q3, Source: Proprietary analysis
The earnings data reveals structural profitability challenges requiring operational reform. Operating margin compression to 0.7% versus industry median of 3.2% highlights cost structure inefficiency, with SG&A expenses consuming 24.5% of revenue and leaving minimal operating profit despite maintained gross margins of 25.2%. The 58.8% YoY operating income decline occurred despite only 3.8% revenue contraction, demonstrating negative operating leverage and fixed cost absorption issues. Sustainable profitability improvement requires either revenue growth restoration or material cost structure rationalization, particularly in the fixed expense base.
Working capital management trends warrant monitoring. The concurrent occurrence of receivables increase (+40.1%), payables extension (+91.7%), and short-term borrowing growth (+32.2%) indicates active liquidity management amid operational headwinds. Trade receivables expansion to 95 DSO while revenue declined signals collection延長 that threatens cash conversion efficiency. The 64.7% short-term debt concentration creates refinancing risk and limits financial flexibility. Future cash flow generation depends critically on receivables collection improvement and sustained payables management.
Earnings quality concerns stem from non-recurring item dependence. Extraordinary gains representing 21.8% of net income indicate that core operating earnings are even weaker than reported figures suggest. Investment securities sales and asset disposals provided one-time support that cannot be relied upon for sustainable results. The company's ability to maintain dividend distributions depends on operating cash flow recovery rather than balance sheet liquidity alone. With forecast payout ratio of 87.5% against projected weak earnings, dividend sustainability requires verification of operating cash generation capacity in upcoming periods.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.